Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2019 4
2020 6
2021 10
2022 17
2023 24
2024 8

Text availability

Article attribute

Article type

Publication date

Search Results

59 results

Results by year

Filters applied: . Clear all
Page 1
Association of Elevated C-Reactive Protein with Worsened Outcomes in Different Histologies of Renal Cortical Tumors: Analysis of the INMARC Registry.
Saitta C, Afari JA, Patil D, Tanaka H, Yuen KL, Wang L, Cortes J, Liu F, Mahmood M, Matian J, Mansour M, Puri D, Cerrato C, Nguyen MV, Hakimi K, Kobayashi M, Fukuda S, Meagher MF, Fujii Y, Master V, Derweesh IH. Saitta C, et al. Among authors: cerrato c. Clin Genitourin Cancer. 2024 Apr 18;22(3):102098. doi: 10.1016/j.clgc.2024.102098. Online ahead of print. Clin Genitourin Cancer. 2024. PMID: 38733897
Effect of Sex on the Oncological Outcomes in Response to Immunotherapy and Antibody-drug Conjugates in Patients with Urothelial and Kidney Cancer: A Systematic Review and a Network Meta-analysis.
Cerrato C, Crocerossa F, Marchioni M, Giannarini G, Gupta S, Albiges L, Brouwer O, Albersen M, Fankhauser C, Grimm MO, Gandaglia G, Roupret M, Mir MC; ESOU Board. Cerrato C, et al. Eur Urol Oncol. 2024 Apr 20:S2588-9311(24)00096-8. doi: 10.1016/j.euo.2024.03.014. Online ahead of print. Eur Urol Oncol. 2024. PMID: 38644155 Review.
Does the Timing of Cytoreductive Nephrectomy Impact Outcomes? Analysis of REMARCC Registry Data for Patients Receiving Tyrosine Kinase Inhibitor Versus Immune Checkpoint Inhibitor Therapy.
Meagher MF, Minervini A, Mir MC, Cerrato C, Rebez G, Autorino R, Hampton L, Campi R, Kriegmair M, Linares E, Hevia V, Musquera M, D'Anna M, Roussel E, Albersen M, Pavan N, Claps F, Antonelli A, Marchioni M, Paksoy N, Erdem S, Derweesh IH. Meagher MF, et al. Among authors: cerrato c. Eur Urol Open Sci. 2024 Mar 25;63:71-80. doi: 10.1016/j.euros.2024.02.001. eCollection 2024 May. Eur Urol Open Sci. 2024. PMID: 38572300 Free PMC article.
Upper Tract Urothelial Cancer: Guideline of Guidelines.
Pandolfo SD, Cilio S, Aveta A, Wu Z, Cerrato C, Napolitano L, Lasorsa F, Lucarelli G, Verze P, Siracusano S, Quattrone C, Ferro M, Bologna E, Campi R, Del Giudice F, Bertolo R, Amparore D, Palumbo S, Manfredi C, Autorino R. Pandolfo SD, et al. Among authors: cerrato c. Cancers (Basel). 2024 Mar 11;16(6):1115. doi: 10.3390/cancers16061115. Cancers (Basel). 2024. PMID: 38539450 Free PMC article. Review.
Outcomes and Techniques of Robotic-Assisted Partial Nephrectomy (RAPN) for Renal Hilar Masses: A Comprehensive Systematic Review.
Pandolfo SD, Wu Z, Campi R, Bertolo R, Amparore D, Mari A, Verze P, Manfredi C, Franco A, Ditonno F, Cerrato C, Ferro M, Lasorsa F, Contieri R, Napolitano L, Tufano A, Lucarelli G, Cilio S, Perdonà S, Siracusano S, Autorino R, Aveta A. Pandolfo SD, et al. Among authors: cerrato c. Cancers (Basel). 2024 Feb 6;16(4):693. doi: 10.3390/cancers16040693. Cancers (Basel). 2024. PMID: 38398084 Free PMC article. Review.
Unraveling the BMI paradox in different renal cortical tumors: insights from the INMARC registry.
Saitta C, Afari JA, Walia A, Patil D, Tanaka H, Hakimi K, Wang L, Meagher MF, Liu F, Nguyen MV, Puri D, Cerrato C, Saidian A, Kobayashi M, Fukuda S, Fujii Y, Master V, Derweesh IH. Saitta C, et al. Among authors: cerrato c. Urol Oncol. 2024 Apr;42(4):119.e1-119.e16. doi: 10.1016/j.urolonc.2023.11.015. Epub 2024 Feb 10. Urol Oncol. 2024. PMID: 38341362
A systematic review of robot-assisted partial nephrectomy outcomes for advanced indications: Large tumors (cT2-T3), solitary kidney, completely endophytic, hilar, recurrent, and multiple renal tumors.
Pandolfo SD, Cerrato C, Wu Z, Franco A, Del Giudice F, Sciarra A, Verze P, Lucarelli G, Imbimbo C, Perdonà S, Cherullo EE, Porpiglia F, Derweesh IH, Autorino R. Pandolfo SD, et al. Among authors: cerrato c. Asian J Urol. 2023 Oct;10(4):390-406. doi: 10.1016/j.ajur.2023.06.001. Epub 2023 Aug 1. Asian J Urol. 2023. PMID: 38024426 Free PMC article. Review.
59 results